Phenofibrate Tablets (Fenofibrate)
Fenofibrate 160mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.
MFDS item code 202002370 · Approved 2020.04.04
This product's status changed to Expired on 2025.04.04. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of primary hyperlipidemia (hypercholesterolemia, hypertriglyceridemia, etc.)
This medication is used to treat primary dyslipidemia, specifically hypercholesterolemia (Type IIa), mixed hypercholesterolemia and hypertriglyceridemia (Type IIb and Type III), and hypertriglyceridemia (Type IV).
○ Adults : Administer fenofibrate 160 mg orally once daily, immediately after a meal. Fenofibrate must be administered in conjunction with dietary therapy. Since this medicine may be less well absorbed on an empty stomach, administer it immediately after a meal (except for the 145 mg formulation). ○ Elderly patients : Dose reduction is generally not required if renal function is not impaired. ○ Patients with renal impairment : Do not administer this medicine to patients with moderate to severe renal impairment (serum creatinine level of 2.5 mg/dL or higher).
○ Pediatric patients : Clinical data on the use of this medicine in pediatric patients are not yet available.
This drug should not be administered to patients with poor liver function. It should also be avoided in patients with moderate to severe kidney function impairment due to the risk of serious muscle damage known as rhabdomyolysis. Pregnant women and those who may become pregnant, as well as nursing mothers, should not use this medication. Patients with a history of allergic reactions to this drug should avoid taking it. Patients with gallbladder disease or gallstones are also advised to avoid this medication. Careful attention is needed for patients who previously exhibited photosensitivity reactions while taking fibrate class drugs or ketoprofen. This drug is not to be administered to children. Patients with biliary cirrhosis or pancreatitis should avoid its use. Patients with genetic metabolic disorders such as lactose intolerance should not receive this medication. In patients with mild renal impairment, dosage should be reduced or intervals between doses increased for careful use. Patients with liver function abnormalities or past histories of liver disease also require caution. Patients with hypoalbuminemia, a history of gallstones, those taking anticoagulants, and the elderly should be carefully administered this drug. This medication may affect the liver and biliary system, leading to elevated liver enzyme levels or the development of gallstones and hepatitis. Skin rash or itching, photosensitivity reactions may occur, and rare cases of hair loss have been reported. Neurological symptoms such as dizziness, headache, and weakness may occur. There is also a risk of thromboembolism, so caution is advised. Myalgia or muscle cramps, and elevated creatine kinase levels may appear, and in severe cases, muscle damage can occur. Allergic reactions such as hives or photodermatitis may occur, so any unusual symptoms should be discussed with a healthcare professional immediately. Gastrointestinal symptoms such as abdominal pain, nausea, vomiting, and diarrhea are common, and pancreatitis may seldom occur. Very rare occurrences of interstitial pulmonary disease, blood cell reductions, and renal function impairment have been reported. Regular liver function tests and blood lipid assessments should be performed before and after administration, and if liver function abnormalities are found, dosage adjustment or discontinuation may be necessary. If cholelithiasis is suspected, gallbladder examinations should be conducted, and treatment should be stopped if gallstones are detected. This drug has many interactions with other medications, especially with statin class drugs that increase the risk of muscle damage, so caution is necessary. Co-administration with anticoagulants increases the risk of bleeding, requiring dosage adjustment and monitoring. When used with antidiabetic drugs, hypoglycemic symptoms may occur, so patient condition should be closely observed. This medication should be avoided during pregnancy as it may harm the fetus, and it is also advisable not to administer while breastfeeding. Elderly individuals have a higher risk of adverse effects due to decreased liver and kidney function, so extra caution is necessary when administering. There are no specific antidotes for overdose, so the prescribed dosage must be followed, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 and 30 degrees Celsius to ensure the drug's effectiveness and safety over time.
White oval film-coated tablet
100 tablets/box [(10 tablets/PTP*10)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Fenofibrate 160mg
Tablet · Prescription medication
Korea Prime Pharma Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Samchundang Pharm Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Yu Yeong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Kyung Dong Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Fenofibrate 160mg
Tablet · Prescription medication
Korea Hyutecs Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.